Panacea Biotec Nine Monthly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
Gross Sales	331.02	520.50	456.54	418.70	329.99
Excise Duty	--	--	--	--	--
Net Sales	331.02	520.50	456.54	418.70	329.99
Other Operating Income	--	--	--	--	--
Other Income	119.88	6.92	5.16	11.88	8.03
Total Income	450.90	527.42	461.70	430.58	338.02
Total Expenditure	423.31	504.17	382.29	384.99	361.33
PBIDT	27.59	23.25	79.41	45.59	(23.31)
Interest	29.61	150.18	138.43	129.52	40.65
PBDT	(2.02)	(126.93)	(59.02)	(83.93)	(63.96)
Depreciation	3.39	32.51	34.02	33.17	79.13
Minority Interest Before NP	--	--	--	--	--
Tax	--	--	0.03	--	0.77
Deferred Tax	15.66	0.12	0.44	7.49	4.34
Reported Profit After Tax	(21.07)	(159.56)	(93.51)	(124.59)	(148.20)
Minority Interest After NP	--	(0.03)	0.08	--	--
Net Profit after Minority Interest	(21.07)	(159.53)	(93.59)	(124.59)	(148.20)
Extra-ordinary Items	(157.79)	--	--	(14.37)	(25.85)
Adjusted Profit After Extra-ordinary item	136.72	(159.53)	(93.59)	(110.22)	(122.35)
EPS (Unit Curr.)	(3.44)	(26.05)	(15.27)	(20.35)	(24.19)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	6.13	6.13	6.13	6.13	6.13
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	8.34	4.47	17.39	10.89	(7.06)
PBDTM(%)	(0.61)	(24.39)	(12.93)	(20.05)	(19.38)
PATM(%)	(6.37)	(30.66)	(20.48)	(29.76)	(44.91)